IOM study calls for increased oral health awareness in the U.S.

This is the point of a new report by the Institute of Medicine (IOM), Advancing Oral Health in America, which underscores a public health crisis that has persisted more than a decade after the U.S. Surgeon General called for aggressively reversing the "silent epidemic" of America's oral health disparity. Many of the most pernicious oral health diseases are highly preventable and treatable.

The IOM study, urging the federal government to launch a new initiative on oral health, aligns with a pioneering community-based dentistry model funded by the Robert Wood Johnson Foundation. Composed of 23 university-based demonstration projects across the country, the Pipeline, Profession, and Practice program (Dental Pipeline) focused on boosting student diversity in dental schools and expanding treatment to underserved patients.

Lower-income African Americans, Hispanics and American Indians tend to suffer oral health disparities and lower access to dental care and prevention compared to white Americans. The IOM study calls for increased public awareness among the underserved populations and widespread oral health literacy among the general population, including oral health professionals.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17